2017
Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy
Lu AJ, Syed JS, Nguyen KA, Nawaf CB, Rosoff J, Spektor M, Levi A, Humphrey PA, Weinreb JC, Schulam PG, Sprenkle PC. Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy. Urology 2017, 105: 118-122. PMID: 28322902, DOI: 10.1016/j.urology.2017.01.048.Peer-Reviewed Original ResearchConceptsMultiparametric magnetic resonance imagingSignificant prostate cancerProstate cancerNegative predictive valueMagnetic resonance imagingSystematic TRUSNegative mpMRIProstate biopsyNegative multiparametric magnetic resonance imagingPredictive valueResonance imagingClinically Significant Prostate CancerDynamic contrast enhancement sequencesTemplate mapping biopsyPrior negative biopsySystematic prostate biopsyOverall cancer detectionProstate-specific antigenTemplate prostate biopsyProstate cancer detectionDiffusion-weighted imagingCancer detectionBiopsy naïveMapping biopsyProstate volume
1995
T2‐weighted MR imaging of the chest: Comparison of electrocardiograph‐triggered conventional and turbo spin‐echo and nontriggered turbo spin‐echo sequences
Haddad J, Rofsky N, Ambrosino M, Naidich D, Weinreb J. T2‐weighted MR imaging of the chest: Comparison of electrocardiograph‐triggered conventional and turbo spin‐echo and nontriggered turbo spin‐echo sequences. Journal Of Magnetic Resonance Imaging 1995, 5: 325-329. PMID: 7633110, DOI: 10.1002/jmri.1880050317.Peer-Reviewed Original ResearchPancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group.
Megibow A, Zhou X, Rotterdam H, Francis I, Zerhouni E, Balfe D, Weinreb J, Aisen A, Kuhlman J, Heiken J. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group. Radiology 1995, 195: 327-32. PMID: 7724748, DOI: 10.1148/radiology.195.2.7724748.Peer-Reviewed Original ResearchConceptsComputed tomographyT1-weighted spin-echo sequencesMR imagingPredictive valueSpin-echo sequenceCross-sectional imaging modalitiesInitial imaging assessmentUnresectable pancreatic carcinomaEvaluation of resectabilityAccuracy of CTT2-weighted spin-echo sequencesNegative predictive valuePositive predictive valueMagnetic resonanceAdult patientsOncology GroupHepatic metastasesVascular invasionPathologic resultsPancreatic adenocarcinomaImaging assessmentPancreatic carcinomaCT scanImaging modalitiesAdenocarcinoma
1994
Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging.
Mitchell D, Saini S, Weinreb J, De Lange E, Runge V, Kuhlman J, Parisky Y, Johnson C, Brown J, Schnall M. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 1994, 193: 49-57. PMID: 8090921, DOI: 10.1148/radiology.193.1.8090921.Peer-Reviewed Original Research
1993
Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
Rofsky N, Weinreb J, Bernardino M, Young S, Lee J, Noz M. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging. Radiology 1993, 188: 53-9. PMID: 8390072, DOI: 10.1148/radiology.188.1.8390072.Peer-Reviewed Original Research